Skip to content

The effect of evaluating perigastric artery by preoperative CTA on the clinical outcome of gastric cancer patients with BMI >=25.0 kg/m2: a multicenter randomized controlled trial

The effect of evaluating perigastric artery by preoperative CTA on the clinical outcome of gastric cancer patients with BMI >=25.0 kg/m2: a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033632
Enrollment
Unknown
Registered
2020-06-07
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Experimental group:CT angiography before operation
control group:Preoperative enhanced CT of upper abdomen

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gastric adenocarcinoma diagnosed by gastroscopy and pathology; 2. Patients aged 18-75 years; 3. Patients with BMI >=25.0kg/m2; 4. Preoperative imaging staging was t1-t4a, N0-3, M0; 5. Patients with laparoscopic surgery.

Exclusion criteria

Exclusion criteria: 1. The patients with T4b, M1 stage, large and unresectable tumor were found during the operation, and those with other malignant tumors were found; 2. Patients with other malignant tumors and low-grade malignant potential tumors (giant cell tumor of bone, pseudomyxoma of appendix, invasive fibroma); 3. The patient has severe other system diseases and cannot tolerate the operation; 4. Patients with non adenocarcinoma type malignant tumor after operation; 5. Patients with gastric stump cancer; 6. Patients with iodine contrast agent allergy; 7. Those who received new adjuvant treatment before operation; 8. Pregnant patients; 9. Patients who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Vascular injury;

Secondary

MeasureTime frame
Number of lymph node dissections;operation time;Postoperative complications;blood loss;5-year overall survival rate;

Countries

China

Contacts

Public ContactYanbing Zhou

Affiliated Hospital of Qingdao University

zhouyanbing999@aliyun.com+86 13708971773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026